Aevis VictoriaXSWX:AEVS -1.19%54 EBITDA Margin % is 4.01% as of Dec. 2025, which is 63% below its 10-year median of 10.81. GuruFocus rates XSWX:AEVS with a GF Score™ of 54/100 and a GF Value™ of CHF17.01 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Aevis Victoria ranks worse than 59.4% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aevis Victoria's EBITDA for the
six
months ended in Dec. 2025 was CHF23 Mil. Aevis Victoria's Revenue for the
six
months ended in Dec. 2025 was CHF585 Mil. Therefore, Aevis Victoria's EBITDA margin for the quarter that ended in Dec. 2025 was 4.01%.
Aevis Victoria (XSWX:AEVS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Aevis Victoria EBITDA Margin % Related Terms
Aevis Victoria EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Aevis Victoria's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:AEVS vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Aevis Victoria's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aevis Victoria EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aevis Victoria's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Aevis Victoria's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aevis Victoria (XSWX:AEVS) has a EBITDA Margin % of 4.01% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aevis Victoria and its competitors. This is 63% below median its historical median of 10.81. Over the past decade, Aevis Victoria's EBITDA Margin % has ranged from 5.36 to 33.00. According to the industry distribution chart, Aevis Victoria ranks #395 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 59.4%.
Is Aevis Victoria's EBITDA Margin % too high?
Aevis Victoria's current EBITDA Margin % of 4.01% is 63% below median its 10-year median of 10.81. Over the past 10 years, this metric has ranged from a low of 5.36 to a high of 33.00. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Aevis Victoria's value of 4.01% is 60.8% below this industry median. Based on the distribution chart, Aevis Victoria ranks #395 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aevis Victoria has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aevis Victoria's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aevis Victoria ranks #395 out of 665 companies for EBITDA Margin %. This places Aevis Victoria in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Aevis Victoria's value of 4.01% is 60.8% below this benchmark. Historically, Aevis Victoria's own EBITDA Margin % has ranged from 5.36 to 33.00 over the past decade. While the company's 10-year median is 10.81 vs. the industry median of 10.24, Aevis Victoria has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aevis Victoria's current EBITDA Margin % of 4.01% is 60.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aevis Victoria and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aevis Victoria's current EBITDA Margin % is 4.01%, which is 63% below median its own 10-year median of 10.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aevis Victoria stock overvalued right now?
Based on GuruFocus' analysis, Aevis Victoria (XSWX:AEVS) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF17.01, compared to a current price of CHF12.45 — trading 26.8% below its estimated fair value. The current EBITDA Margin % is 4.01%, which is 63% below median its 10-year median of 10.81 and 60.8% below the Healthcare Providers & Services industry median of 10.24. Aevis Victoria's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aevis Victoria (XSWX:AEVS), the current EBITDA Margin % is 4.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aevis Victoria (XSWX:AEVS) Overvalued in 2026?
Based on GuruFocus' analysis, Aevis Victoria stock appears to be undervalued.
The current stock price of CHF12.45 is trading 26.8% below its estimated GF Value™ of CHF17.01.
GuruFocus considers Aevis Victoria to be Modestly Undervalued.
Key valuation signals for XSWX:AEVS:
EBITDA Margin %: 4.01% (63% below median its 10-year median of 10.81)
GF Value™: CHF17.01 vs. price of CHF12.45 (26.8% below fair value)
Industry Position: 60.8% below the Healthcare Providers & Services median (#395 of 665)
No single metric tells the full story. See the XSWX:AEVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aevis Victoria SA is a medical care company with five segments: Healthcare, Hospitality, Real Estate, Others, and Corporate. The Healthcare business segment operates private hospitals and clinics. The Hospitality business segment owns and operates hospitals. The Real Estate segment operates healthcare-related real estate properties. The Others segment provides ambulance services, such as urgent patient transport and hospital transfers. The Corporate segment operates other miscellaneous business activities. It generates the vast majority of its revenue in Healthcare segment.
54GF Score
Get the complete analysis for XSWX:AEVS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AEVS has been successfully added to your 
